机构：[1]Department of Neurosurgery, Dongzhimen Hospital, University of Chinese Medicine, Beijing 100700, China[2]Beijing Huicheng Medical Research Institute, Beijing 100048, China[3]Institute of Neurorestoratology, Third Medical Center of General Hospital of PLA, Beijing 100039, China[4]Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen 518035, China北京大学深圳医院深圳市康宁医院深圳医学信息中心[5]Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China[6]Department of Neurosurgery, Zhujiang Hospital of Southern Medical University, The National Key Clinical Specialty, TheEngineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain FunctionRepair and Regeneration, Guangzhou 510282, Guangdong, China[7]Department of Neurology, Beijing Rehabilitation Hospital of Capital Medical University, Beijing 100144, China[8]Department of Neurosurgery, Rudong Peopleʹs Hospital, Nantong 226400, Jiangsu, China[9]Department of Neurology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan430030, Hubei, China华中科技大学同济医学院附属同济医院[10]Department of Neurosurgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong ProvinceHospital of Chinese Medical, Guangzhou 510120, Guangdong, China广东省中医院[11]Department of Neurosurgery, Fourth Hospital of China Medical University, Shenyang 110084, Liaoning, China[12]Department of Neurosurgery, The First Affiliated Hospital, Zhengjiang University School of Medicine, Hangzhou 310003, Zhejiang, China[13]Department of Neurosurgery, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji 311800, Zhejiang, China[14]Department of Neurology, Shenzhen University General Hospital, Shenzhen 518055, China深圳大学总医院深圳市康宁医院深圳医学信息中心[15]The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Henan Joint InternationalLaboratory of Intracerebral Hemorrhagic Brain Injury, Zhengz hou 450001, Henan, China
Brainstem hemorrhage (mainly pontine hemorrhage caused by hypertension) has the clinical characteristics of acute onset, rapid progress, high mortality, and high disability rate. Due to the complexity of the brainstem's anatomical structure and functional importance, it is generally recognized that brainstem treatment is difficult and risky, so it has been regarded as a restricted area of surgery. However, in recent years, continuous progress is being made in many areas, including microsurgical technology, stereotactic technology, robot-assisted surgery, neuroendoscopy, and theoretical and clinical practice of neurorestoration, aiding in the understanding, diagnosis, and treatment of brainstem hemorrhage injuries. The Chinese Association of Neurorestoratology (CANR; Preparatory) and the China Committee of International Association of Neurorestoratology (IANR-China Committee) organized relevant experts to formulate this clinical guideline to diagnose and restore damaged nerves after brainstem hemorrhages, promote a standardized diagnosis, and neurorestoratologically treat this disease.
第一作者机构：[1]Department of Neurosurgery, Dongzhimen Hospital, University of Chinese Medicine, Beijing 100700, China
通讯作者：
推荐引用方式(GB/T 7714)：
Chen Lin,Chen Tao,Mao Gengsheng,et al.Clinical neurorestorative therapeutic guideline for brainstem hemorrhage (2020 China version)[J].JOURNAL OF NEURORESTORATOLOGY.2020,8(4):232-240.doi:10.26599/JNR.2020.9040024.
APA：
Chen, Lin,Chen, Tao,Mao, Gengsheng,Chen, Baodong,Li, Mingchang...&Xue, Mengzhou.(2020).Clinical neurorestorative therapeutic guideline for brainstem hemorrhage (2020 China version).JOURNAL OF NEURORESTORATOLOGY,8,(4)
MLA：
Chen, Lin,et al."Clinical neurorestorative therapeutic guideline for brainstem hemorrhage (2020 China version)".JOURNAL OF NEURORESTORATOLOGY 8..4(2020):232-240
